Toby Eyre/X
Dec 5, 2023, 12:57
Toby Eyre: Big news in CLL
Toby Eyre, CLL specialist at Oxford University Hospitals, announced on X/Twitter:
“Big news in CLL. Pirtobrutinib now FDA-approved in patients who have received a prior cov BTKi and BCL2i following results of the BRUIN trial. Jaypirca (pirtobrutinib) now Approved by U.S. FDA for the Treatment of Adult Patients with CLL.”
For the article click here.
Source: Toby Eyre/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46